Target intelligence / Profile preview

Hepatitis B Virus preS1 Protein (preS1)

Target
preS1
Molecular classification
Viral protein, Envelope protein, Surface antigen, Intrinsically disordered protein
01

Overview

The preS1 protein is a domain of the large envelope (surface) protein (L-HBsAg) of the hepatitis B virus (HBV). It plays a critical role in viral infectivity, host cell entry, and immune recognition. The N-terminal segment of preS1 contains a myristoylation site at glycine-2 and an essential receptor-binding site (RBS), mediating attachment to human hepatocytes via interaction with sodium taurocholate co-transporting polypeptide (NTCP), which serves as the primary cellular receptor for HBV entry.

Other names
L-HBsAg preS1 domainHBV preS1pre-S1 domainLarge envelope protein preS1
02

Mechanism of action

preS1 mediates attachment to human hepatocytes via interaction with sodium taurocholate co-transporting polypeptide (NTCP), which serves as the primary cellular receptor for HBV entry. Myristoylated synthetic peptides specific for the N-terminal [pre-S1] domain can bind to hepatocyte plasma membranes and block infection in vitro and in vivo. Mutations within key hydrophobic regions of preS1 abolish both infectivity and membrane fusion capability.

03

Biological functions

Host cell receptor bindingViral entryMembrane fusionTranscriptional activation (in certain contexts)Immune modulation
04

Disease associations

Hepatitis BChronic hepatitisLiver cirrhosisHepatocellular carcinomaViral infectionHepatic inflammation
05

Safety considerations

Potential for immune-mediated liver damageDevelopment of drug resistanceOff-target effects of preS1-targeting therapiesDeregulation of innate/adaptive immunityContribution to hepatic inflammationSensitization of hepatocytes to cell death via unfolded protein response activationPotential promotion of carcinogenesis through chronic immune stimulation or direct effects on host gene regulation
06

Biomarkers

preS1 antigen levels in serumAnti-preS1 antibodies

Beyond the preview

Go deeper on Hepatitis B Virus preS1 Protein (preS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B Virus preS1 Protein (preS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call